Roelof Rongen - 04 Nov 2026 Form 4 Insider Report for GRI Bio, Inc. (GRI)

Reporting relationship
Director
Issuer ticker
GRI
Reported as of
04 Nov 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Nov 2026, 17:18:29 UTC
Prior SEC filing
22 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Leanne Kelly, Attorney-in-Fact
Filing notes and source

Key filing fact

Roelof Rongen filed Form 4 for GRI Bio, Inc. (GRI) on 13 Nov 2026.

Key facts

  • This page summarizes Roelof Rongen's Form 4 filing for GRI Bio, Inc. (GRI).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 13 Nov 2026, 17:18.

Change

  • Previous filing in this sequence was filed on 22 Sep 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001698966 Primary reporting owner

Rongen Roelof

Relationship
Director
Address
C/O GRI BIO, INC., 2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA
Signature
/s/ Leanne Kelly, Attorney-in-Fact
Signature date
11 Nov 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+3,935
Change %
Price
$0.000000*
Shares after
3,935
Date
04 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,935
Exercise price
$1.43
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option vests in 4 equal quarterly installments such that the stock option is fully vested on the first anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .